The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Captured microbes are then neutralized on engineered microbicidal surfaces
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Growing patent filings and tier-2 innovators reflect expanding national research base
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Subscribe To Our Newsletter & Stay Updated
